AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy

AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy: In a U.S. trial, the two-dose vaccine reduced symptomatic disease by 79% and severe Covid-19 and hospitalization by 100%.